In patients with liver cirrhosis, proinflammatory interleukins correlate with health-related quality of life irrespective of minimal hepatic encephalopathy

European Journal of Gastroenterology and Hepatology

Volumn 25, Issue 12, 2013, Pages 1402-1407

  Wunsch, Ewa ^a   Koziarska, Dorota ^b   Milkiewicz, Małgorzata ^c   Naprawa, Grzegorz ^d   Nowacki, Przemysław ^b   Hartleb, Marek ^e   Milkiewicz, Piotr ^a,f  

^a Liver Research Laboratories   (Poland)

^b Department of Neurology ^*  (Poland)

^c POMERANIAN MEDICAL UNIVERSITY   (Poland)

^d Prof A Sokolowski's Specialistic Hospital   (Poland)

^e MEDICAL UNIVERSITY OF SILESIA   (Poland)

^f MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

health related quality of life; inflammation; interleukins; liver cirrhosis; minimal hepatic encephalopathy

Indexed keywords

INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6;

ADULT; ARTICLE; BLOOD ANALYSIS; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CRITICAL FLICKER FUSION; DOUBLE ANTIBODY SANDWICH ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATIC ENCEPHALOPATHY; HOSPITAL PATIENT; HUMAN; LIVER CIRRHOSIS; LIVER DYSFUNCTION; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SHORT FORM 36;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKINS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHOMETRICS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84887065772     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328365a447     Document Type: Article

References (25)

1. Lee FY, Lu RH, Tsai YT, Lin HC, Hou MC, Li CP, et al. Plasma interleukin-6 levels in patients with cirrhosis. Relationship to endotoxemia, tumor necrosis factor-alpha, and hyperdynamic circulation. Scand J Gastroenterol 1996; 31:500-505.
2. Tilg H, Wilmer A, Vogel W, Herold M, Nö lchen B, Judmaier G, et al. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992; 103:264-274.
3. Genesca J, Gonzalez A, Segura R, Catalan R, Marti R, Varela E, et al. Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis. Am J Gastroenterol 1999; 94:169-177.
4. Wiest R, Das S, Cadelina G, Garcia-Tsao G, Milstien S, Groszmann RJ. Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility. J Clin Invest 1999; 104:1223-1233.
5. Jain L, Sharma BC, Sharma P, Srivastava S, Agrawal A, Sarin SK. Serum endotoxin and inflammatory mediators in patients with cirrhosis and hepatic encephalopathy. Dig Liver Dis 2012; 44:1027-1031.
6. Montoliu C, Piedrafita B, Serra MA, del Olmo JA, Urios A, Rodrigo JM, et al. IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy. J Clin Gastroenterol 2009; 43:272-279.
7. Onal IK, Akdogan M, Oztas E, Balci M, Kurt M, Kacar S, et al. Does interleukin-18 play a role in the pathogenesis of hepatic encephalopathy? Hepatogastroenterology 2011; 58:497-502.
8. Luo M, Li L, Yang EN, Dai CY, Liang SR, Cao WK. Correlation between interleukin-6 and ammonia in patients with overt hepatic encephalopathy due to cirrhosis. Clin Res Hepatol Gastroenterol 2012.
9. Felipo V, Urios A, Montesinos E, Molina I, Garcia-Torres ML, Civera M, et al. Contribution of hyperammonemia and inflammatory factors to cognitive impairment in minimal hepatic encephalopathy. Metab Brain Dis 2012; 27:51-58.
10. Weissenborn K. Psychometric tests for diagnosing minimal hepatic encephalopathy. Metab Brain Dis 2013; 28:227-229.
11. Maldonado-Garza HJ, Vá zquez-Elizondo G, Gaytá n-Torres JO, Flores-Rendón AR, Cárdenas-Sandoval MG, Bosques-Padilla FJ. Prevalence of minimal hepatic encephalopathy in cirrhotic patients. Ann Hepatol 2011; 10 (Suppl 2):S40-S44.
12. Loria A, Escheik C, Gerber NL, Younossi ZM. Quality of life in cirrhosis. Curr Gastroenterol Rep 2013; 15:1-7.
13. Román E, Có rdoba J, Torrens M, Guarner C, Soriano G. Falls and cognitive dysfunction impair health-related quality of life in patients with cirrhosis. Eur J Gastroenterol Hepatol 2013; 25:77-84.
14. Les I, Doval E, Flavia M, Jacas C, Cárdenas G, Esteban R, et al. Quality of life in cirrhosis is related to potentially treatable factors. Eur J Gastroenterol Hepatol 2010; 22:221-227.
15. Afendy A, Kallman JB, Stepanova M, Younoszai Z, Aquino RD, Bianchi G, et al. Predictors of health-related quality of life in patients with chronic liver disease. Aliment Pharmacol Ther 2009; 30:469-476.
16. Younossi Z, Guyatt G, Kiwi M, Boparai N, King D. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut 1999; 45:295-300.
17. Brazier JE, Harper R, Jones NM, O'Cathain A, Thomas KJ, Usherwood T, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992; 305:160-164.
18. Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC, Seeff L, et al. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology 1977; 72:573-583.
19. Wunsch E, Szymanik B, Post M, Marlicz W, Myd?owska M, Milkiewicz P. Minimal hepatic encephalopathy does not impair health-related quality of life in patients with cirrhosis: a prospective study. Liver Int 2011; 31:980-984.
20. Kircheis G,Wettstein M, Timmermann L, Schnitzler A, Häussinger D. Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology 2002; 35:357-366.
21. Jacob A, Brorson JR, Alexander JJ. Septic encephalopathy: inflammation in man and mouse. Neurochem Int 2011; 58:472-476.
22. Handa O, Stephen J, Cepinskas G. Role of endothelial nitric oxide synthasederived nitric oxide in activation and dysfunction of cerebrovascular endothelial cells during early onsets of sepsis. Am J Physiol Heart Circ Physiol 2008; 295:H1712-H1719.
23. Sola E,Watson H, Graupera I, Turón F, Barreto R, Rodr?́guez E, et al. Factors related to quality of life in patients with cirrhosis and ascites: relevance of serum sodium concentration and leg edema. J Hepatol 2012; 57:1199-1206.
24. Moscucci F, Nardelli S, Pentassuglio I, Pasquale C, Ridola L, Merli M, et al. Previous overt hepatic encephalopathy rather than minimal hepatic encephalopathy impairs health-related quality of life in cirrhotic patients. Liver Int 2011; 31:1505-1510.
25. Amodio P, Campagna F, Olianas S, Iannizzi P, Mapelli D, Penzo M, et al. Detection of minimal hepatic encephalopathy: normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study. J Hepatol 2008; 49:346-353.